Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma L Barber

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Gynecologic Oncology|December 24, 2017
Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phaseArthur-Quan Tran, Daniel O Erim, Stephanie A Sullivan, et al.
Obstetrics and Gynecology|November 10, 2015
Association of Preoperative Thrombocytosis and Leukocytosis With Postoperative Morbidity and Mortality Among Patients With Ovarian CancerEmma L Barber, John F Boggess, Linda Van Le, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2025
Exploratory evaluation of the somatic and immunologic landscape of primary and metastatic cervical cancer to better inform future clinical trial developmentVictoria Cerda, Bobbie J Rimel, Jacob Mercer, et al.
Gynecologic Oncology|October 9, 2013
Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasionChristine H Kim, Fady Khoury-Collado, Emma L Barber, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 23, 2013
Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer stagingChristine H Kim, Robert A Soslow, Kay J Park, et al.
Journal of Computer Assisted Tomography|October 8, 2024
Uterine Sarcoma or Degenerating Fibroid? Validating the New Consensus Magnetic Resonance Imaging Algorithm for Evaluating Atypical Uterine MassesJeanne M Horowitz, Camila Lopes Vendrami, Yuri S Velichko, et al.
Abdominal Radiology (New York)|June 29, 2023
Gynecologic oncology tumor board: the central role of the radiologistHannah S Recht, Kimberly L Shampain, Marta N Flory, et al.
NPJ Genomic Medicine|December 2, 2024
Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancerHao Huang, Russel Keathley, Ujin Kim, et al.
European Journal of Gynaecological Oncology|March 6, 2023
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution studyTalayeh S Ghezelayagh, Emily S Wu, Emma L Barber, et al.
The New England Journal of Medicine|November 1, 2018
Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical CancerAlexander Melamed, Daniel J Margul, Ling Chen, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Gynecologic Oncology|December 24, 2017
Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phaseArthur-Quan Tran, Daniel O Erim, Stephanie A Sullivan, et al.
Obstetrics and Gynecology|November 10, 2015
Association of Preoperative Thrombocytosis and Leukocytosis With Postoperative Morbidity and Mortality Among Patients With Ovarian CancerEmma L Barber, John F Boggess, Linda Van Le, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2025
Exploratory evaluation of the somatic and immunologic landscape of primary and metastatic cervical cancer to better inform future clinical trial developmentVictoria Cerda, Bobbie J Rimel, Jacob Mercer, et al.
Gynecologic Oncology|October 9, 2013
Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasionChristine H Kim, Fady Khoury-Collado, Emma L Barber, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 23, 2013
Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer stagingChristine H Kim, Robert A Soslow, Kay J Park, et al.
Journal of Computer Assisted Tomography|October 8, 2024
Uterine Sarcoma or Degenerating Fibroid? Validating the New Consensus Magnetic Resonance Imaging Algorithm for Evaluating Atypical Uterine MassesJeanne M Horowitz, Camila Lopes Vendrami, Yuri S Velichko, et al.
Abdominal Radiology (New York)|June 29, 2023
Gynecologic oncology tumor board: the central role of the radiologistHannah S Recht, Kimberly L Shampain, Marta N Flory, et al.
NPJ Genomic Medicine|December 2, 2024
Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancerHao Huang, Russel Keathley, Ujin Kim, et al.
European Journal of Gynaecological Oncology|March 6, 2023
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution studyTalayeh S Ghezelayagh, Emily S Wu, Emma L Barber, et al.
The New England Journal of Medicine|November 1, 2018
Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical CancerAlexander Melamed, Daniel J Margul, Ling Chen, et al.
Pageof 8